Related Experiment Video
Updated: Jun 21, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Role of LMO7 in cancer (Review)
Qun Zeng1, Tingting Jiang1, Jing Wang1
1Hunan Key Laboratory of The Research and Development of Novel Pharmaceutical Preparations, The Hunan Provincial University Key Laboratory of The Fundamental and Clinical Research on Functional Nucleic Acid, Changsha Medical University, Changsha, Hunan 410000, P.R. China.
Abstract:
Cancer constitutes a multifaceted ailment characterized by the dysregulation of numerous genes and pathways. Among these, LIM domain only 7 (LMO7) has emerged as a significant player in various cancer types, garnering substantial attention for its involvement in tumorigenesis and cancer progression. This review endeavors to furnish a comprehensive discourse on the functional intricacies and mechanisms of LMO7 in cancer, with a particular emphasis on its potential as both a therapeutic target and prognostic indicator. It delves into the molecular attributes of LMO7, its implications in cancer etiology and the underlying mechanisms propelling its oncogenic properties. Furthermore, it underscores the extant challenges and forthcoming prospects in targeting LMO7 for combating cancer.
Insights
The LIM domain only 7 (LMO7) protein plays a key role in cancer development and progression. Understanding LMO7
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cancer is a complex disease involving gene and pathway dysregulation.
- LIM domain only 7 (LMO7) is implicated in tumorigenesis and cancer progression across various cancer types.
Purpose of the Study:
- To provide a comprehensive review of LMO7's functional roles and mechanisms in cancer.
- To explore LMO7's potential as a therapeutic target and prognostic biomarker.
Main Methods:
- Literature review focusing on molecular attributes of LMO7.
- Analysis of LMO7's role in cancer etiology and oncogenic mechanisms.
- Examination of challenges and prospects in LMO7-targeted cancer therapy.
Main Results:
- LMO7 exhibits significant involvement in the initiation and advancement of multiple cancers.
- The molecular functions of LMO7 contribute to its oncogenic properties.
Conclusions:
- LMO7 is a critical factor in cancer pathogenesis.
- Targeting LMO7 presents a promising avenue for cancer treatment and prognosis.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
PI3K/mTOR/AKT Signaling Pathway
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Abnormal Proliferation
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
lncRNA - Long Non-coding RNAs

